Publication at Faculty of Medicine in Hradec Králové |
2019
Abstract
Multiple sclerosis is a chronic inflammatory autoimmune disease of the central nervous systém affecting most commonly young adults.There has been tremendous progress in the treatment of relapsing-remitting MS over recent years. In the era of expanding treatment options the issue of safety and regular monitoring has become an important part of the decision-making proces when choosing proper treatment.
This paper reviews the most frequent adverse affects associated with disease-modifying drugs used for MS.